Efficacy and Safety Study of KN019 in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate
Clinical trial NCT04038970 · COMPLETED
Trial details
- NCT number
- NCT04038970
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-08
- Primary completion
- 2022-07-28
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.